We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
(+2.3%)
Cap. Flow
-$59.5M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$40.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$30.9M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$26.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17M |
| 5 |
Amazon
AMZN
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$68.4M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$29.2M |
| 3 |
Apple
AAPL
|
+$23.6M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$20.5M |
| 5 |
VAL
Valspar
VAL
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.4% |
| 2 | Technology | 15.29% |
| 3 | Healthcare | 13.69% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Coherus Oncology
CHRS
$217M
| $607K | ﹤0.01% |
42,282
+6,105
| +17% | +$117K |
|
|
CUDA
2202
DELISTED
Barracuda Networks, Inc.
CUDA
| $607K | ﹤0.01% |
26,330
+2,718
| +12% | +$59.9K |
|
2203
Inovio Pharmaceuticals
INO
$85.6M
| $606K | ﹤0.01% |
6,441
-141
| -2% | -$12.1K |
|
2204
Kforce
KFRC
$1.05B
| $606K | ﹤0.01% |
30,931
-1,715
| -5% | -$34.5K |
|
2205
Beazer Homes USA
BZH
$888M
| $605K | ﹤0.01% |
44,068
+523
| +1% | +$6.76K |
|
|
ACTA
2206
DELISTED
Actua Corp
ACTA
| $605K | ﹤0.01% |
43,084
-7,708
| -15% | -$109K |
|
2207
Peapack-Gladstone Financial
PGC
$815M
| $599K | ﹤0.01% |
19,153
+1,800
| +10% | +$55.2K |
|
|
REGI
2208
DELISTED
Renewable Energy Group, Inc.
REGI
| $599K | ﹤0.01% |
46,266
-1,645
| -3% | -$18.5K |
|
2209
Akebia Therapeutics
AKBA
$338M
| $596K | ﹤0.01% |
41,510
+518
| +1% | +$6.57K |
|
|
LJPC
2210
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $596K | ﹤0.01% |
20,012
+3,618
| +22% | +$104K |
|
2211
Ingles Markets
IMKTA
$1.72B
| $595K | ﹤0.01% |
17,867
+450
| +3% | +$17.9K |
|
2212
eHealth
EHTH
$41.9M
| $594K | ﹤0.01% |
31,601
-995
| -3% | -$15.9K |
|
2213
Angi Inc
ANGI
$247M
| $593K | ﹤0.01% |
4,635
+97
| +2% | +$9.57K |
|
|
WIFI
2214
DELISTED
Boingo Wireless, Inc.
WIFI
| $593K | ﹤0.01% |
39,631
-1,170
| -3% | -$17.7K |
|
2215
Stoneridge
SRI
$200M
| $592K | ﹤0.01% |
38,406
+2,475
| +7% | +$41.5K |
|
|
WSR
2216
DELISTED
Whitestone REIT
WSR
| $592K | ﹤0.01% |
48,325
+10,305
| +27% | +$129K |
|
|
CARB
2217
DELISTED
Carbonite Inc
CARB
| $592K | ﹤0.01% |
27,163
+6,810
| +33% | +$140K |
|
|
CTT
2218
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $591K | ﹤0.01% |
52,017
+175
| +0.3% | +$2.03K |
|
|
DVAX
2219
DELISTED
Dynavax Technologies
DVAX
| $584K | ﹤0.01% |
60,503
+15,865
| +36% | +$103K |
|
|
NXRT
2220
NexPoint Residential Trust
NXRT
$689M
| $583K | ﹤0.01% |
23,420
-1,563
| -6% | -$39K |
|
|
XCRA
2221
DELISTED
Xcerra Corporation
XCRA
| $581K | ﹤0.01% |
59,465
-4,845
| -8% | -$47.1K |
|
|
NEX
2222
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $580K | ﹤0.01% |
+36,258
| New | +$534K |
|
|
UMH
2223
UMH Properties
UMH
$1.34B
| $579K | ﹤0.01% |
33,958
-261
| -0.8% | -$4.3K |
|
2224
Powell Industries
POWL
$6.79B
| $578K | ﹤0.01% |
54,216
+15
| +0% | +$167 |
|
2225
Gorman-Rupp
GRC
$2.07B
| $577K | ﹤0.01% |
22,640
+63
| +0.3% | +$1.69K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
- RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
- RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
- RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
- RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
- RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.
Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.